Polyphemusins inhibit the production of pro-inflammatory cytokines TNF-α and IL-6 through LPS-stimulated macrophages, protect mice from endotoxemia, and block the development of endotoxin shock in an animal model. The gene discussed is TNF; the disease is serum lipopolysaccharide activity.